Page 34 | Certara

Publication

Learn-confirm in model-informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform

Immunogenicity against therapeutic proteins frequently causes attrition owing to its potential impact on pharmacokinetics, pharmacodynamics,…

CertaraFebruary 10, 2025

Blog

EU CTIS: Europe’s New Clinical Trial Information System

The EU CTIS is now fully implemented, replacing EudraCT as the central hub for clinical…

CertaraFebruary 10, 2025

Poster

Simulations to Inform Dose Selection for a Phase 2b Trial Investigating TOUR006, a Fully Human Anti-IL6 Antibody, for Treatment of Thyroid Eye Disease

CertaraFebruary 7, 2025

Blog

Measuring metabolites in index clinical DDI studies

February 7, 2025A key drug development safety consideration is whether the drug candidate will interact…

CertaraFebruary 7, 2025

On-Demand Webinar

Machine Learning for Population PK Model Selection: Theory and Practice

Three of Certara's expert modelers provide a gentle introduction to machine learning in our field.…

CertaraFebruary 7, 2025

On-Demand Webinar

Standards for All: Controlling Your Metadata for Vendors, Study Sites, and Submission Datasets

Director of Product, Certara's Pinnacle 21Senior Principal CDISC Consultant, Certara's Pinnacle 21Achieve submission ready conformance…

CertaraFebruary 7, 2025

On-Demand Webinar

Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling

With the release of Version 24, the Simcyp Simulator introduces cutting-edge enhancements that further elevate…

CertaraFebruary 7, 2025

Publication

Population Pharmacokinetic and Pharmacodynamic Analysis of Navtemadlin in Patients with Relapsed and Refractory (R/R) Myelofibrosis (MF) and Other Myeloid or Solid Tumor Malignancies

This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2…

CertaraFebruary 6, 2025

Conference

ACDM

- - Booth

CertaraFebruary 5, 2025

Video

Behind the Science: Meet Pharmacometrics Expert Ahmed Abulfathi

CertaraFebruary 5, 2025

Learn-confirm in model-informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform

EU CTIS: Europe’s New Clinical Trial Information System

Simulations to Inform Dose Selection for a Phase 2b Trial Investigating TOUR006, a Fully Human Anti-IL6 Antibody, for Treatment of Thyroid Eye Disease

Measuring metabolites in index clinical DDI studies

Machine Learning for Population PK Model Selection: Theory and Practice

Standards for All: Controlling Your Metadata for Vendors, Study Sites, and Submission Datasets

Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling

Population Pharmacokinetic and Pharmacodynamic Analysis of Navtemadlin in Patients with Relapsed and Refractory (R/R) Myelofibrosis (MF) and Other Myeloid or Solid Tumor Malignancies

ACDM

Behind the Science: Meet Pharmacometrics Expert Ahmed Abulfathi

Newsletter sign up

Quick links

Solutions

Contact